Latest receivables for 600789.SS: $1.6B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2026), 600789.SS shows a receivables of $1.6B. That compares with $1.7B in the prior-year period — down 5.3% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 600789.SS's receivables is now $1.6B (was $1.7B) — a 5.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Shandong Lukang Pharmaceutical ,Ltd. is outperforming or lagging.
Tracking 600789.SS's receivables over time shows whether Shandong Lukang Pharmaceutical ,Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $1.6B That compares with $1.7B in the prior-year period — down 5.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has Shandong Lukang Pharmaceutical ,Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $1.6B) with ownership activity and broader fundamentals.